MedTrace Logo

Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)

NCT04548739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2024-01-11

No results posted yet for this study

Summary

Children supported by Extra-Corporeal Membrane Oxygenation (ECMO) present a high risk of neurological complications and cerebral autoregulation (CA) impairment may be a risk factor. The first objective is to investigate the association between CA impairments and neurological outcome assessed by the onset of an ANE. The secondary objective is to study the underlying mechanisms influencing CA.

Conditions

  • Acute Respiratory Distress Syndrome (ARDS)
  • Cardiogenic Shock
  • Cardiac Arrest

Sponsors & Collaborators

  • Istituto Giannina Gaslini

    collaborator OTHER

  • Pediatric Intensive Care Unit, Trousseau University Hospital, France

    collaborator UNKNOWN

  • Pediatric Intensive Care Unit, Necker University Hospital, France

    collaborator UNKNOWN

  • Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, UK

    collaborator UNKNOWN

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Nicolas JORAM, MD · Nantes University Hospital

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2023-10-16
Completion
2023-10-16

Countries

  • France
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04548739 on ClinicalTrials.gov